Use Auxilium Pharmaceuticals Inc. management performance with your portfolios to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.
Auxilium Management Effectiveness
The company has return on total asset (ROA) of (5.17) % which means that it has lost $5.17 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (25.84) % meaning that it created substantial loss on money invested by shareholders.
Auxilium Profit Margins
The company has Profit Margin (PM) of (8.16) % which may suggest that it does not properly executes on its current pricing strategies or is unable to controls all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (8.34) % which suggests for every dolor of sales it generated a net operating loss of -0.08.
Auxilium Pharmaceuticals Inc. is rated fifth in number of employees category among related companies. The total workforce of Drug Related Products industry is presently estimated at about 16,690. Auxilium holds roughly 526 in number of employees claiming about 3% of equities under Drug Related Products industry.
Mr. Adrian Adams is President, Chief Executive Officer, Director of Auxilium Pharmaceuticals, Inc., effective December 7, 2011. Prior to joining Auxilium, he served as Chief Executive Officer and Chairman of the Board of...
Mr. Rolf A. Classon is Independent Chairman of Board of Directors of Auxilium Pharmaceuticals, Inc., since April 2005. He formerly served as Vice Chairman from March 2005 to April 2005 and has served as one of directors ...
Auxilium employes about 526 people. The company is managed by 22 executives with total tenure of roughly 49 years, averanging almost 2.0 years of service per executive having 23.0 employee per reported executive.
Return on Auxilium Manpower
Revenue Per Employee
531.5 K
Revenue Per Executive
12.7 M
Net Loss Per Employee
43.4 K
Net Loss Per Executive
1 M
Working Capital Per Employee
334.1 K
Working Capital Per Executive
8 M
Auxilium Earnings Per Share
According to company disclosure Auxilium Pharmaceuticals Inc. has Earnings Per Share of -0.48 times. This is 145.28% lower than that of Healthcare sector, and 167.61% lower than that of Drug Related Products industry, The Earnings Per Share for all stocks is 132.0% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
